Rapid Fc-mediated surface modification of liposomes with antibodies for selective targeting of pancreatic tumors.
This study introduces a versatile platform for targeted drug delivery that addresses the complexities of conventional immunoliposome preparation. Traditional methods for conjugating a monoclonal antibody (mAb) to the surface of liposomes require target-specific chemical modification for each antibody, frequently result...